The upward revision of the clawback tax as a result of the requests of the European Commission represents a real tragedy for Romanian patients and a major risk for the future of the pharmaceutical industry in Romania, said on Tuesday the Industrial Manufacturers of Medicines in Romania Employers association, PRIMER, according to Agerpres. „PRIMER appeals […]Medicines’ producers: Clawback fee’s upward revision means serious compromise of patients’ access to medicines
The upward revision of the clawback tax as a result of the requests of the European Commission represents a real tragedy for Romanian patients and a major risk for the future of the pharmaceutical industry in Romania, said on Tuesday the Industrial Manufacturers of Medicines in Romania Employers association, PRIMER, according to Agerpres. „PRIMER appeals […]
